🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-522630-31-00
Completed Phase I

Evaluation of AG-181 in Subjects 18 to 69 Years of Age With Phenylketonuria

2025-522630-31-00 · tracked via the Priya Life Science EU tracker
Sponsor
Agios Pharmaceuticals Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Nutritional and Metabolic Diseases
Decision date
03/04/2026
Enrollment target
10
Sites
Poland

Condition studied

Phenylketonuria

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-522630-31-00 on CTIS ↗ ← All trials in the EU